Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular and biochemical parasitology (Print)

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLBIOPARA.2004.06.014PMID 15500913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia

  2004cited by this paper
• TROSY in NMR studies of the structure and function of large biological macromolecules.

  2003cited by this paper
• Suramin and Suramin Analogues Inhibit Merozoite Surface Protein-1 Secondary Processing and Erythrocyte Invasion by the Malaria Parasite Plasmodium falciparum*

  2003cited by this paper
• Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate.

  2003cited by this paper
• The Human Immune Response to Plasmodium falciparum Includes Both Antibodies That Inhibit Merozoite Surface Protein 1 Secondary Processing and Blocking Antibodies

  2002cited by this paper
• NMR analysis of a 900K GroEL–GroES complex

  2002cited by this paper
• Mapping the Epitope of an Inhibitory Monoclonal Antibody to the C-terminal DNA-binding Domain of HIV-1 Integrase*

  2002cited by this paper
• Four-dimensional NMR spectroscopy of a 723-residue protein: chemical shift assignments and secondary structure of malate synthase g.

  2002cited by this paper
• Mapping protein-protein interactions in solution by NMR spectroscopy.

  2002cited by this paper
• Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to Malaria

  2001cited by this paper
• Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

  2001cited by this paper
• NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.

  2000cited by this paper
• Expression of deuterium-isotope-labelled protein in the yeast Pichia pastoris for NMR studies

  2000cited by this paper
• Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.

  2000cited by this paper
• A novel NMR method for determining the interfaces of large protein–protein complexes

  2000cited by this paper
• Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1.

  1999cited by this paper
• Single Transition-to-single Transition Polarization Transfer (ST2-PT) in [15N,1H]-TROSY

  1998cited by this paper
• Passive Immunization with Antibodies against Three Distinct Epitopes on Plasmodium yoelii Merozoite Surface Protein 1 Suppresses Parasitemia

  1998cited by this paper
• NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies.

  1998cited by this paper
• Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution.

  1997cited by this paper
• Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human Antibodies

  1997cited by this paper
• Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein

  1994cited by this paper
• Immunization against malaria with a recombinant protein

  1994cited by this paper
• Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein.

  1994cited by this paper
• Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.

  1993cited by this paper
• A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice

  1993cited by this paper
• Nuclear magnetic resonance for studying peptide-antibody complexes by transferred nuclear Overhauser effect difference spectroscopy.

  1991cited by this paper
• A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion- inhibiting antibodies

  1990cited by this paper
• Use of deuterium labelling in NMR studies of antibody combining site structure

  1990cited by this paper
• A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.

  1989cited by this paper
• Three-dimensional structure of antibodies.

  1988cited by this paper
• Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex.

  1987cited by this paper
• Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites.

  1985cited by this paper

• NMR Based SARS-CoV-2 Antibody Screening

  2021cites this paper
• Recent developments of methyl-labeling strategies in Pichia pastoris for NMR spectroscopy.

  2020cites this paper
• Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog

  2019cites this paper
• TCR-contacting residues orientation and HLA-DRβ* binding preference determine long-lasting protective immunity against malaria.

  2016cites this paper
• Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers under Chloroquine Prophylaxis: A Randomized Controlled Trial

  2016cites this paper
• Epitope mapping by solution NMR spectroscopy

  2015cites this paper
• Generierung Plasmodium falciparum-spezifischer humaner Antikörperformate aus Epstein-Barr Virus-transformierten B Lymphozyten semi-immuner Individuen

  2015cites this paper
• PLASMODIUM FALCIPARUM IMMUNIZATION UNDER CHLOROQUINE Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial

  2015cites this paper
• Plasmodium life-cycle specific protection and humoral responses against malaria after chemoprophylaxis and sporozoite immunization

  2015cites this paper
• The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design

  2014cites this paper
• Conserved regions of Plasmodium vivax potential vaccine candidate antigens in Sri Lanka: conscious in silico analysis of prospective conformational epitope regions.

  2014cites this paper
• Memory B-Cell and Antibody Responses Induced by Plasmodium falciparum Sporozoite Immunization

  2014cites this paper
• A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila

  2014cites this paper
• design , antibody specificity and implications for malaria vaccine 19 1 merozoite surface protein Plasmodium yoelii The structure of

  2014cites this paper
• Antimalarial Activity of Cupredoxins

  2013influential citation
• Advances in nuclear magnetic resonance for drug discovery.

  2012cites this paper
• Fine specificity of anti-MSP119 antibodies and multiplicity of Plasmodium falciparum Merozoite Surface Protein 1 types in individuals in Nigeria with sub-microscopic infection

  2010cites this paper
• A generic approach to evaluate how B-cell epitopes are surface-exposed on protein structures

  2010cites this paper
• Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum

  2010cites this paper
• blood-stage vaccine candidate of Plasmodium falciparum

  2010cites this paper
• The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria

  2009cites this paper
• Inhibition of Erythrocyte Invasion and Plasmodium falciparum Merozoite Surface Protein 1 Processing by Human Immunoglobulin G1 (IgG1) and IgG3 Antibodies

  2009cites this paper
• Biological Activities of Anti-Merozoite Surface Protein-1 Antibodies Induced by Adjuvant-Assisted Immunizations in Mice with Different Immune Gene Knockouts

  2008cites this paper
• Production of High-Affinity Human Monoclonal Antibody Fab Fragments to the 19-Kilodalton C-Terminal Merozoite Surface Protein 1 of Plasmodium falciparum

  2007cites this paper
• Identifying merozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum protein family members specifically binding to human erythrocytes suggests a new malarial parasite-redundant survival mechanism.

  2007cites this paper
• Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.

  2007cites this paper
• Structural studies on Plasmodium vivax merozoite surface protein-1.

  2007cites this paper
• Structural basis of the collagen‐binding mode of discoidin domain receptor 2

  2007influential citation
• Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes.

  2007cites this paper
• Nuclear magnetic resonance-based screening methods for drug discovery.

  2006cites this paper
• Interaction of malaria parasite‐inhibitory antibodies with the merozoite surface protein MSP119 by computational docking

  2006cites this paper
• High road, low road? Choices and challenges on the pathway to a malaria vaccine

  2006cites this paper
• Functional and immunological insights from the three-dimensional structures of Plasmodium surface proteins.

  2006cites this paper
• Opinion: antibody-based therapies for malaria.

  2005cites this paper
• Antibody-based therapies for malaria

  2005cites this paper
• Precise epitope mapping of malaria parasite inhibitory antibodies by TROSY NMR cross-saturation.

  2005cites this paper